# ImageneBio, Inc.: filings

IMA · Nasdaq · CIK 1835579 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ima.md) · [Financials](/companies/ima/financials.md) · [Filings](/companies/ima/filings.md) · [Insiders](/companies/ima/insiders.md)

## Reports and events: 96 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 85, 8-K 53, 3 29, 10-Q 17, 424B3 13, SC 13G/A 12, CORRESP 11, EFFECT 9, SCHEDULE 13G/A 9, S-8 7, UPLOAD 7, SCHEDULE 13G 6, 10-K 5, 4/A 5, DEF 14A 5, S-4/A 5, SC 13G 5, SCHEDULE 13D/A 5, 425 4, ARS 4, DEFA14A 4, S-3 4, SC 13D/A 3, 424B5 2, D 2, POS AM 2, S-1 2, SC 13D 2, SCHEDULE 13D 2, SEC STAFF LETTER 2, 3/A 1, 424B4 1, 8-A12B 1, 8-K/A 1, CERT 1, DRS 1, DRS/A 1, DRSLTR 1, PRE 14A 1, S-1/A 1, S-4 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-05 | 08:10 ET | [10-Q](/filings/0001193125-26-333920.md) | Quarterly report, period 2026-06-30 | 0001193125-26-333920 |
| 2026-08-05 | 08:05 ET | [8-K](/filings/0001193125-26-333912.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-333912 |
| 2026-07-23 | 16:25 ET | [8-K](/filings/0001193125-26-314167.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-314167 |
| 2026-06-26 | 16:01 ET | [8-K](/filings/0001193125-26-285424.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-285424 |
| 2026-06-17 | 16:05 ET | [8-K](/filings/0001193125-26-274139.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-274139 |
| 2026-05-07 | 16:24 ET | [10-Q](/filings/0001193125-26-212073.md) | Quarterly report, period 2026-03-31 | 0001193125-26-212073 |
| 2026-05-07 | 16:12 ET | [8-K](/filings/0001193125-26-211935.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-211935 |
| 2026-04-30 | 16:31 ET | [DEF 14A](/filings/0001140361-26-018267.md) | Proxy statement, period 2026-06-16 | 0001140361-26-018267 |
| 2026-04-29 | 19:07 ET | [SCHEDULE 13D/A](/filings/0000947871-26-000483.md) | Ownership report, active investor, amended | 0000947871-26-000483 |
| 2026-04-21 | 16:00 ET | [SCHEDULE 13D](/filings/0001193125-26-166691.md) | Ownership report, active investor | 0001193125-26-166691 |
| 2026-04-13 | 07:10 ET | [8-K](/filings/0001193125-26-151942.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-26-151942 |
| 2026-03-17 | 16:30 ET | [8-K](/filings/0001193125-26-110945.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-110945 |
| 2026-03-10 | 08:33 ET | [10-K](/filings/0001193125-26-099434.md) | Annual report, period 2025-12-31 | 0001193125-26-099434 |
| 2026-03-10 | 08:16 ET | [8-K](/filings/0001193125-26-099422.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-099422 |
| 2026-02-17 | 16:15 ET | [8-K](/filings/0001193125-26-054684.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-054684 |
| 2025-12-18 | 16:05 ET | [8-K](/filings/0001193125-25-324798.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-324798 |
| 2025-11-19 | 07:50 ET | [8-K](/filings/0001193125-25-286984.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-286984 |
| 2025-11-12 | 07:30 ET | [10-Q](/filings/0001193125-25-275932.md) | Quarterly report, period 2025-09-30 | 0001193125-25-275932 |
| 2025-11-12 | 07:25 ET | [8-K](/filings/0001193125-25-275910.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-275910 |
| 2025-11-05 | 16:05 ET | [8-K](/filings/0001193125-25-266889.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-266889 |
| 2025-10-29 | 08:00 ET | [8-K](/filings/0001193125-25-254697.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement | 0001193125-25-254697 |
| 2025-10-22 | 09:03 ET | [8-K](/filings/0001193125-25-245823.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-245823 |
| 2025-10-10 | 16:45 ET | [8-K](/filings/0001193125-25-237161.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-237161 |
| 2025-09-08 | 16:18 ET | [S-1](/filings/0001193125-25-198360.md) | Registration statement | 0001193125-25-198360 |
| 2025-08-12 | 17:19 ET | [8-K/A](/filings/0001193125-25-179093.md) | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001193125-25-179093 |
| 2025-08-05 | 17:15 ET | [8-K](/filings/0001193125-25-173626.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001193125-25-173626 |
| 2025-08-01 | 16:59 ET | [8-K](/filings/0001193125-25-171747.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-171747 |
| 2025-07-30 | 21:28 ET | [SCHEDULE 13D/A](/filings/0000947871-25-000711.md) | Ownership report, active investor, amended | 0000947871-25-000711 |
| 2025-07-29 | 16:53 ET | [SCHEDULE 13D/A](/filings/0001415889-25-020462.md) | Ownership report, active investor, amended | 0001415889-25-020462 |
| 2025-07-29 | 06:04 ET | [8-K](/filings/0001193125-25-167089.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.06 Item not in the standard list; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-167089 |
| 2025-07-28 | 14:16 ET | [SCHEDULE 13D/A](/filings/0001373604-25-000095.md) | Ownership report, active investor, amended | 0001373604-25-000095 |
| 2025-07-25 | 12:23 ET | [8-K](/filings/0001193125-25-165170.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-165170 |
| 2025-07-24 | 17:17 ET | [10-Q](/filings/0000950170-25-098414.md) | Quarterly report, period 2025-06-30 | 0000950170-25-098414 |
| 2025-07-24 | 09:18 ET | [8-K](/filings/0001193125-25-163990.md) | 8.01 Other events | 0001193125-25-163990 |
| 2025-07-22 | 16:20 ET | [8-K](/filings/0001193125-25-162584.md) | 8.01 Other events | 0001193125-25-162584 |
| 2025-07-16 | 16:40 ET | [8-K](/filings/0001193125-25-159910.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-159910 |
| 2025-07-15 | 16:50 ET | [8-K](/filings/0001193125-25-159400.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-159400 |
| 2025-07-11 | 08:34 ET | [8-K](/filings/0001193125-25-157867.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-157867 |
| 2025-07-01 | 16:15 ET | [8-K](/filings/0001193125-25-154016.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-154016 |
| 2025-06-18 | 20:23 ET | [SCHEDULE 13D/A](/filings/0000947871-25-000619.md) | Ownership report, active investor, amended | 0000947871-25-000619 |
| 2025-06-16 | 12:21 ET | [SCHEDULE 13D](/filings/0001373604-25-000088.md) | Ownership report, active investor | 0001373604-25-000088 |
| 2025-05-08 | 08:00 ET | [10-Q](/filings/0000950170-25-066411.md) | Quarterly report, period 2025-03-31 | 0000950170-25-066411 |
| 2025-03-06 | 08:10 ET | [10-K](/filings/0000950170-25-034188.md) | Annual report, period 2024-12-31 | 0000950170-25-034188 |
| 2024-12-23 | 08:37 ET | [8-K](/filings/0001193125-24-283722.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-283722 |
| 2024-11-07 | 08:00 ET | [10-Q](/filings/0000950170-24-122818.md) | Quarterly report, period 2024-09-30 | 0000950170-24-122818 |
| 2024-08-08 | 16:05 ET | [10-Q](/filings/0000950170-24-093880.md) | Quarterly report, period 2024-06-30 | 0000950170-24-093880 |
| 2024-07-12 | 16:06 ET | [8-K](/filings/0001193125-24-178568.md) | 5.02 Departure or appointment of officers or directors | 0001193125-24-178568 |
| 2024-06-10 | 16:05 ET | [8-K](/filings/0001193125-24-158321.md) | 5.07 Shareholder vote results | 0001193125-24-158321 |
| 2024-05-28 | 16:24 ET | [8-K](/filings/0001193125-24-148112.md) | 2.05 Exit or disposal costs; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-148112 |
| 2024-05-13 | 16:33 ET | [10-Q](/filings/0000950170-24-058715.md) | Quarterly report, period 2024-03-31 | 0000950170-24-058715 |

Page 1 of 2. [Older](/companies/ima/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.